July 9, 2026 · Form 4 insider transaction
Smith Mary L. bought 5,834 shares of PTC Therapeutics, Inc. at $42.95 per share, a transaction worth $250.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.